Tinnen Quoted in Reorg About COVID Premium in Siemens-Varian Acquisition
August 6, 2020
Reorg
Partner Clyde Tinnen was quoted in the Reorg article, “VAR SMMNY Covid-19 Premium Reflects Long-Term Market Uncertainty,” about whether he is seeing companies using Covid premiums in mergers and acquisitions. Siemens Healthineers was reported to have included a Covid-19 bonus in its pending acquisition of Varian Medical Systems. Tinnen told Reorg that he has not seen significant premiums as part of deal terms.
(Subscription required.)
People
Related News
February 6, 2026
In the News
Louis Lehot Featured for Insights on Evolution of Dealmaking
Foley & Lardner LLP partner Louis Lehot highlighted the evolution of dealmaking in the Silicon Valley Business Journal article, "The Old Playbook Doesn't Work Anymore."
February 6, 2026
In the News
Gregory Husisian on What U.S.-India Trade Deal Means for Fashion Supply Chains
Foley & Lardner LLP Gregory Husisian discussed the broader geopolitical evolution of the US-India agreement in the Vogue Business article, “What the US-India Trade Deal Could Mean for Fashion’s Supply Chains.”
February 2, 2026
In the News
Aaron Maguregui Outlines AI Regulation and Pharma Challenges in Health Care
Foley & Lardner LLP partner Aaron Maguregui examining the regulatory landscape for AI in the health care industry in the PharmaVoice article, “As artificial intelligence increasingly takes on new patient-facing roles, laws lag behind.”